News
Earnings season slows this week, with investors waiting on NVIDIA’s earnings on August 27. Retail sales and inflation ...
Erythroid cell patterns in neoplasms show distinct genomic profile and poor venetoclax response, new research suggests.
An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...
Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that ...
Amgen Inc (NASDAQ:AMGN) shares were slightly lower in premarket trading despite posting better-than-expected quarterly profit ...
For developers, OpenAI claims GPT-5 is its most powerful coding model to date, outperforming GPT-o3 in benchmarks and ...
Strand Therapeutics announced on Thursday that it landed a $153 million Series B funding led by Kinnevik. The company’s ...
The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...
Amgen reported total revenue of $9.2 billion, topping the consensus of $8.9 billion, and non-GAAP earnings of $6.02 per share ...
Q2 2025 Earnings Call Transcript August 5, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $6.02, expectations ...
1d
Zacks Investment Research on MSNIs Trending Stock Amgen Inc. (AMGN) a Buy Now?
Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results